维普中文期刊产品整合服务
46篇 您的检索式:作者名="Hedvat"
    题名 作者 年代 出处 被引量
1The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate显示文摘Patrick S. Ward Jay Patel David R. Wise Omar Abdel-Wahab Bryson D. Bennett Hilary A. Coller Justin R. Cross Valeria R. Fantin Cyrus V. Hedvat Alexander E. Perl Joshua D. Rabinowitz Martin Carroll Shinsan M. Su Kim A. Sharp Ross L. Levine Craig B. Thompson 2010Cancer Cell2010,,3:2
2Melan-A(A103) and inhibin expression in ovarian neoplasms显示文摘Yao D X Soslow R A Hedvat C V 2003Appl Immunohistochem Mol Morphol2003,11,3:1
3Inhibition of HER-kinase activation prevents ERK-mediated degradation of PPARgamma 显示文摘Hedvat M Jain A Carson D A st al 2004Cancer Cell2004,5,6:1
4Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma显示文摘Hedvat CV Hegde A Chaganti RS 2002Hum Pathol2002,23,:1
5Endoplasmic reticulum protein BI-1 regulates Ca(2)(+)-mediated bioenergetics to promote autophagy显示文摘Sano R Hou Y C Hedvat M 2012Genes&Development2012,26,:1
6Objective quantifi- cation of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a compari- son of digital image analysis with manual methods显示文摘Tang LH Gonen M Hedvat C 2012Am J Surg Pathol2012,36,12:1
7Wetting force measurements on single fibres显示文摘Miller B Penn L S Hedvat E S 1983Colloids Sutfaces1983,6,:1
8Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies显示文摘Abdel-Wahab O Mullally A Hedvat C 2009Blood2009,114,1:1
9Genetic characterization of TET1,TET2,and TET3 alterations in myeloid malignancies显示文摘ABDEL-WAHAB O MULLALLY A HEDVAT C 2009Blood2009,114,1:1
10melan-A(A103)and inhibin expression in ovarianneoplasms显示文摘Yao DX Soslow RA Hedvat CV 2003Appl immunohistochem Mol Morphol2003,11,3:1
11Expression of p63 in diffuse large B-cell lymphoma显示文摘Hedvat C V Teruya-Feldstein J Puig P 2005Appl hnmunohistochem Mol Morphol2005,13,13:1
12Genetic char-acterization of TET1,TET2,and TET3 alterations in mye-loid malignancies显示文摘Abdel-Wahab O Mullally A Hedvat C 2009Blood2009,114,1:1
13Immunohistochemical analysis of BRAF ( V600E ) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions 显示文摘Busam K J Hedvat C Pulitzer M 2013Am J Surg Patho12013,37,3:1
14The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors 显示文摘Hedvat M Huszar D Herrmarm A 2009Cancer cell2009,16,6:1
15Genetic characterization of TETI , TET2, and TET3 alterations in myeloid malignancies 显示文摘Abdel-Wahab O Mullally A Hedvat C 2009Blood2009,114,1:1
16Genetic character-ization of TET1,TET2,and TET3 alterations in myeloid malignancies显示文摘Abdel-Wahab O Mullally A Hedvat C 2009Blood2009,114,:1
17Human granulocyte colony-stimulating factor: Biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines显示文摘AVALOS B R GASSON J C HEDVAT C 1990Blood1990,75,:1
18The jak2 inhibitor azdl480potently blocks stat3 signaling and oncogenesis in solid tumors 显示文摘Hedvat M Huszar D Herrmann A 2009Cancer Cell2009,16,6:1
19Application of tissue microarray technology to the study of non-Hodgkin 's lymphoma显示文摘Hedvat CV Hegde A Chaganti RS 2002Hum Pathol2002,33,10:1
20Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma显示文摘Schaffel R Hedvat CV Teruya-Feldstein J 2010Ann Oncol2010,21,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费